Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial (vol 382, pg 1705, 2013)

被引：0
|
作者：
Baeten, D.
Baraliakos, X.
Braun, J.
机构：
来源：
LANCET | 2014年 / 383卷 / 9928期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1548 / 1548
页数：1
相关论文
共 50 条
  • [21] TOCILIZUMAB (TCZ) IS NOT EFFECTIVE FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS (AS): RESULTS OF A PHASE 2, INTERNATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Sieper, J.
    Porter-Brown, B.
    Thompson, L.
    Harari, O.
    Dougados, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 110 - 111
  • [22] Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. (vol 373, pg 633, 2009)
    Gottlieb, A.
    Menter, A.
    Mendelsohn, A.
    LANCET, 2009, 373 (9672): : 1340 - 1340
  • [23] SECUKINUMAB, A HUMAN ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, IMPROVES ACTIVE PSORIATIC ARTHRITIS AND INHIBITS RADIOGRAPHIC PROGRESSION: EFFICACY AND SAFETY DATA FROM A PHASE 3 RANDOMIZED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Tahir, Hasan
    Mease, Philip
    McInnes, Iain B.
    Kirkham, Bruce
    Kavanaugh, Arthur
    Rahman, Proton
    van der Heijde, Desiree
    Landewe, Robert
    Nash, Peter
    Pricop, Luminita
    Yuan, Jiacheng
    Richards, Hanno
    Mpofu, Shephard
    RHEUMATOLOGY, 2015, 54 : 137 - 138
  • [24] SECUKINUMAB, A HUMAN ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, IMPROVES ACTIVE PSORIATIC ARTHRITIS AND INHIBITS RADIOGRAPHIC PROGRESSION: EFFICACY AND SAFETY DATA FROM A PHASE 3 RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Nash, P.
    Mease, P.
    McInnes, I.
    Kirkham, B.
    Kavanaugh, A.
    Rahman, P.
    Van Der Heijde, D.
    Landewe, R.
    Pricop, L.
    Yuan, J.
    Richards, H.
    Mpofu, S.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 41 - 42
  • [25] Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial
    Haibel, H.
    Fendler, C.
    Listing, J.
    Callhoff, J.
    Braun, J.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 243 - 246
  • [26] Efficacy of Oral Prednisolone in Active Ankylosing Spondylitis: Results of a Double-Blind, Randomised, Placebo-Controlled Short-Term Trial
    Lunzer, R.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2013, 20 (04): : 174 - 175
  • [27] Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum
    Nelson-Piercy, C
    Fayers, P
    de Swiet, M
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2001, 108 (01): : 9 - 15
  • [28] Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.
    Mease, Philip
    McInnes, Iain B.
    Kirkham, Bruce
    Kavanaugh, Arthur
    Rahman, Proton
    van der Heijde, Desiree
    Landewe, Robert
    Nash, Peter
    Pricop, Luminita
    Yuan, Jiacheng
    Richards, Hanno
    Mpofu, Shephard
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S423 - S424
  • [29] Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial
    Brooklyn, T
    Shetty, A
    Bowden, J
    Griffiths, C
    Dunnill, G
    Forbes, A
    Greenwood, R
    Probert, C
    GASTROENTEROLOGY, 2005, 128 (04) : A26 - A26
  • [30] Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression
    Silvers, KM
    Woolley, CC
    Hamilton, FC
    Watts, PM
    Watson, RA
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2005, 72 (03): : 211 - 218
12345